Towards global control of parasitic diseases in the Covid-19 era: One Health and the future of multisectoral global health governance

被引:12
|
作者
Ung, Lawson [1 ,2 ,3 ]
Stothard, J. Russell [4 ]
Phalkey, Revati [5 ,6 ]
Azman, Andrew S. [7 ,8 ]
Chodosh, James [1 ,2 ]
Hanage, William P. [3 ]
Standley, Claire J. [6 ,9 ]
机构
[1] Harvard Med Sch, Massachusetts Eye & Ear, Infect Dis Inst, Boston, MA 02115 USA
[2] Harvard Med Sch, Massachusetts Eye & Ear, Dept Ophthalmol, Boston, MA 02115 USA
[3] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol & Ctr Commun Dis Dynam, Boston, MA 02115 USA
[4] Univ Liverpool Liverpool Sch Trop Med, Ctr Neglected Trop Dis, Dept Trop Dis Biol, Liverpool, Merseyside, England
[5] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham, England
[6] Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany
[7] Johns Hopkins Bloomberg, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[8] Univ Geneva, Inst Global Hlth, Fac Med, Geneva, Switzerland
[9] Georgetown Univ, Ctr Global Hlth Sci & Secur, Washington, DC 20057 USA
来源
ADVANCES IN PARASITOLOGY, VOL 114 | 2021年 / 114卷
关键词
NEGLECTED TROPICAL DISEASES; MALARIA CONTROL; INSECTICIDE RESISTANCE; LYMPHATIC FILARIASIS; POTENTIAL IMPACT; AFRICA; SCHISTOSOMIASIS; CHALLENGES; PROGRAMS; ONCHOCERCIASIS;
D O I
10.1016/bs.apar.2021.08.007
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Human parasitic infections-including malaria, and many neglected tropical diseases (NTDs)-have long represented a Gordian knot in global public health: ancient, persistent, and exceedingly difficult to control. With the coronavirus disease (Covid-19) pandemic substantially interrupting control programmes worldwide, there are now mounting fears that decades of progress in controlling global parasitic infections will be undone. With Covid-19 moreover exposing deep vulnerabilities in the global health system, the current moment presents a watershed opportunity to plan future efforts to reduce the global morbidity and mortality associated with human parasitic infections. In this chapter, we first provide a brief epidemiologic overview of the progress that has been made towards the control of parasitic diseases between 1990 and 2019, contrasting these fragile gains with the anticipated losses as a result of Covid-19. We then argue that the complementary aspirations of the United Nations Sustainable Development Goals (SDGs) and the World Health Organization (WHO)'s 2030 targets for parasitic disease control may be achieved by aligning programme objectives within the One Health paradigm, recognizing the interdependence between humans, animals, and the environment. In so doing, we note that while the WHO remains the preeminent international institution to address some of these transdisciplinary concerns, its underlying challenges with funding, authority, and capacity are likely to reverberate if left unaddressed. To this end, we conclude by reimagining how models of multisectoral global health governance-combining the WHO's normative and technical leadership with greater support in allied policy-making areas-can help sustain future malaria and NTD elimination efforts.
引用
收藏
页码:1 / 26
页数:26
相关论文
共 50 条
  • [31] China's COVID-19 Control Strategy and Its Impact on the Global Pandemic
    Ding, Difeng
    Zhang, Ruilian
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [32] The "Corona Warriors"? Community health workers in the governance of India's COVID-19 response
    Nichols, Carly
    Jalali, Falak
    Fischer, Harry
    POLITICAL GEOGRAPHY, 2022, 99
  • [33] Lessons learnt from COVID-19 to reduce mortality and morbidity in the Global South: addressing global vaccine equity for future pandemics
    Martin, Rebecca
    Maleche, Allan
    Gay, Jill
    Fatima, Haram
    BMJ GLOBAL HEALTH, 2024, 9 (01):
  • [34] Epidemiological specificities of COVID-19 in Africa: Current or future public health concern?
    Hardy, E. J. L.
    Flori, P.
    ANNALES PHARMACEUTIQUES FRANCAISES, 2021, 79 (02): : 216 - 226
  • [35] Towards sustainable partnerships in global health: the case of the CRONICAS Centre of Excellence in Chronic Diseases in Peru
    Jaime Miranda, J.
    Bernabe-Ortiz, Antonio
    Diez-Canseco, Francisco
    Malaga, German
    Cardenas, Maria K.
    Carrillo-Larco, Rodrigo M.
    Lazo-Porras, Maria
    Moscoso-Porras, Miguel
    Amalia Pesantes, M.
    Ponce, Vilarmina
    Araya, Ricardo
    Beran, David
    Busse, Peter
    Boggio, Oscar
    Checkley, William
    Garcia, Patricia J.
    Huicho, Luis
    Leon-Velarde, Fabiola
    Lescano, Andres G.
    Mohr, David C.
    Pan, William
    Peiris, David
    Perel, Pablo
    Rabadan-Diehl, Cristina
    Rivera-Chira, Maria
    Sacksteder, Katherine
    Smeeth, Liam
    Trujillo, Antonio J.
    Wells, Jonathan C. K.
    Yan, Lijing L.
    Garcia, Hector H.
    Gilman, Robert H.
    GLOBALIZATION AND HEALTH, 2016, 12
  • [36] Immunomics in one health: understanding the human, animal, and environmental aspects of COVID-19
    Gao, Jing
    Zhang, Chutian
    Wheelock, Asa M.
    Xin, Siming
    Cai, Hui
    Xu, Lei
    Wang, Xiao-jun
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [37] Global concerns of dental and oral health workers during COVID-19 outbreak: a scope study on the concerns and the coping strategies
    Bastani, Peivand
    Mohammadpour, Mohammadtaghi
    Ghanbarzadegan, Arash
    Kapellas, Kostas
    Do, Loc Giang
    SYSTEMATIC REVIEWS, 2021, 10 (01)
  • [38] Global Healthcare Infrastructure and Africa in Times of COVID-19: Insights for Sustainable Development and Future Pandemics
    Diop, Samba
    Asongu, Simplice A.
    JOURNAL OF HEALTH MANAGEMENT, 2023, 25 (03) : 613 - 619
  • [39] Towards equitable genomics governance in Africa: Guiding principles from theories of global health governance and the African moral theory of Ubuntu
    Munung, Nchangwi Syntia
    Vries, Jantina
    Pratt, Bridget
    BIOETHICS, 2022, 36 (04) : 411 - 422
  • [40] The Story behind COVID-19: Animal Diseases at the Crossroads of Wildlife, Livestock and Human Health
    De Sadeleer, Nicolas
    Godfroid, Jacques
    EUROPEAN JOURNAL OF RISK REGULATION, 2020, 11 (02) : 210 - 227